ARTICLE | Financial News

Virobay, Xenon set IPO terms

October 7, 2014 2:24 AM UTC

Virobay Inc. (Menlo Park, Calif.) and Xenon Pharmaceuticals Inc. (Burnaby, B.C.) both set terms for their proposed IPOs on NASDAQ

Virobay plans to sell 3.8 million shares at $12-$14. At $13, Virobay would raise $50 million and be valued at $169 million. Piper Jaffray; JMP Securities; Cantor Fitzgerald; and Summer Street Research Partners are underwriters. ...